91.61
1.82 (2.03%)
| Penutupan Terdahulu | 89.79 |
| Buka | 89.75 |
| Jumlah Dagangan | 328,086 |
| Purata Dagangan (3B) | 1,182,670 |
| Modal Pasaran | 2,613,926,400 |
| Harga / Jualan (P/S) | 6.84 |
| Harga / Buku (P/B) | 9.06 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 |
| Margin Keuntungan | -11.69% |
| Margin Operasi (TTM) | -5.22% |
| EPS Cair (TTM) | -1.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 39.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 44.61% |
| Nisbah Semasa (MRQ) | 3.25 |
| Aliran Tunai Operasi (OCF TTM) | -1.90 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 17.79 M |
| Pulangan Atas Aset (ROA TTM) | -1.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -16.61% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menaik | Bercampur |
| Health Information Services (Global) | Menaik | Bercampur | |
| Stok | GeneDx Holdings Corp. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 0.5 |
| Purata | -1.00 |
|
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world’s substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 12.56% |
| % Dimiliki oleh Institusi | 102.71% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Oracle Investment Management Inc | 31 Mar 2025 | 969,954 |
| Zweig-Dimenna Associates Llc | 31 Mar 2025 | 457,100 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 115.00 (Guggenheim, 25.53%) | Beli |
| Median | 110.00 (20.07%) | |
| Rendah | 78.00 (Wells Fargo, -14.86%) | Pegang |
| Purata | 98.60 (7.63%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 73.59 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 09 Jul 2025 | 110.00 (20.07%) | Beli | 91.88 |
| Guggenheim | 30 Jun 2025 | 115.00 (25.53%) | Beli | 92.31 |
| Jefferies | 09 May 2025 | 80.00 (-12.67%) | Beli | 59.14 |
| TD Securities | 01 May 2025 | 110.00 (20.07%) | Beli | 62.32 |
| Wells Fargo | 01 May 2025 | 78.00 (-14.86%) | Pegang | 62.32 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FEELEY KEVIN | - | 91.88 | -5,278 | -484,943 |
| STUELAND KATHERINE | - | 91.88 | -3,220 | -295,854 |
| Jumlah Keseluruhan Kuantiti Bersih | -8,498 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -780,796 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 91.88 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| STUELAND KATHERINE | Pegawai | 09 Jul 2025 | Jual automatik (-) | 3,220 | 91.88 | 295,854 |
| FEELEY KEVIN | Pegawai | 09 Jul 2025 | Jual automatik (-) | 5,278 | 91.88 | 484,943 |
| FEELEY KEVIN | Pegawai | 09 Jul 2025 | Pelaksanaan pilihan | 1,245 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |